3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
4
Sponsor Class
OTHER
4
Study Type
Observational
3
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
3
Genitourinary
1
Conditions
Breast Neoplasms
11
Osteoporosis
5
Prostatic Neoplasms
4
Neoplasms
4
Multiple Myeloma
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Testicular Neoplasms
1
Smoldering Multiple Myeloma
1
Regional Osteoporosis as a Result of Chemotherapy
1
Recurrence
1
Polycystic Ovary Syndrome
1
Paraganglioma, Extra-Adrenal
1
Pain
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Menstruation Disturbances
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lymphedema
1
Leukemia
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Depression
1
Cicatrix
1
Cardiovascular Diseases
1
Carcinoma, Transitional Cell
1
Interventions
Gemcitabine
109
Paclitaxel
92
Carboplatin
79
pembrolizumab
75
Bevacizumab
75
Surveys and Questionnaires
70
Docetaxel
69
Cisplatin
67
Nivolumab
48
Exercise
48
Capecitabine
48
Cyclophosphamide
47
Sorafenib
43
Fluorouracil
43
Irinotecan
42
Pemetrexed
37
Albumin-Bound Paclitaxel
35
Radiotherapy
34
Dexamethasone
34
Blood Specimen Collection
34
Oxaliplatin
31
Leucovorin
31
Erlotinib Hydrochloride
31
trametinib
30
130-nm albumin-bound paclitaxel
29
Cetuximab
28
Therapeutics
26
Ipilimumab
26
Standard of Care
25
Methods
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Completed
×
Neoplasms
×
Absorptiometry, Photon
×
Clear all
NCT03690401
2024-10-28
PostSOZO
Prisma Health-Upstate
Completed
52 enrolled
NCT03784911
2024-10-28
DuringSOZO
Prisma Health-Upstate
Completed
51 enrolled
NCT01641172
2024-04-19
TASTY
University Medical Center Groningen
Phase 4
Completed
140 enrolled
NCT02806154
2023-07-19
FRACTION
University Hospital, Toulouse
Completed
144 enrolled